Viewing Study NCT01032850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:56 PM
Ignite Modification Date: 2026-02-03 @ 1:10 PM
Study NCT ID: NCT01032850
Status: TERMINATED
Last Update Posted: 2021-06-02
First Post: 2009-12-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
Sponsor: New Mexico Cancer Research Alliance
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None INST 0820 View
None sorafenib View
None capecitabine View
None hepatocellular carcinoma View
None lung View
None nexavar View
None xeloda View
None liver cancer View